Similar articles for PMID: 27565934

Year	Number of Results
2002	1
2014	1
2015	11
2016	37
2017	48
2018	34
2019	33
2020	12
2021	2
2022	4
2023	2
2024	0

1

Nivolumab-induced organizing pneumonitis in a patient with lung sarcomatoid carcinoma.

Gounant V, Brosseau S, Naltet C, Opsomer MA, Antoine M, Danel C, Khalil A, Cadranel J, Zalcman G. Gounant V, et al. Lung Cancer. 2016 Sep;99:162-5. doi: 10.1016/j.lungcan.2016.07.010. Epub 2016 Jul 15. Lung Cancer. 2016. PMID: 27565934

2

Anti-PD-1 Inhibitor-Related Pneumonitis in Non-Small Cell Lung Cancer.

Nishino M, Chambers ES, Chong CR, Ramaiya NH, Gray SW, Marcoux JP, Hatabu H, Jänne PA, Hodi FS, Awad MM. Nishino M, et al. Cancer Immunol Res. 2016 Apr;4(4):289-93. doi: 10.1158/2326-6066.CIR-15-0267. Epub 2016 Feb 10. Cancer Immunol Res. 2016. PMID: 26865455 Free PMC article.

3

A pilot trial of nivolumab treatment for advanced non-small cell lung cancer patients with mild idiopathic interstitial pneumonia.

Fujimoto D, Morimoto T, Ito J, Sato Y, Ito M, Teraoka S, Otsuka K, Nagata K, Nakagawa A, Tomii K. Fujimoto D, et al. Lung Cancer. 2017 Sep;111:1-5. doi: 10.1016/j.lungcan.2017.06.008. Epub 2017 Jun 17. Lung Cancer. 2017. PMID: 28838377 Clinical Trial.

4

Pneumonitis From Anti-PD-1/ PD-L1 Therapy.

Balaji A, Verde F, Suresh K, Naidoo J. Balaji A, et al. Oncology (Williston Park). 2017 Oct 15;31(10):739-46, 754. Oncology (Williston Park). 2017. PMID: 29083466

5

Development of psoriatic arthritis during nivolumab therapy for metastatic non-small cell lung cancer, clinical outcome analysis and review of the literature.

Ruiz-Bañobre J, Pérez-Pampín E, García-González J, Gómez-Caamaño A, Barón-Duarte FJ, López-López R, Vázquez-Rivera F. Ruiz-Bañobre J, et al. Lung Cancer. 2017 Jun;108:217-221. doi: 10.1016/j.lungcan.2017.04.007. Epub 2017 Apr 14. Lung Cancer. 2017. PMID: 28625638 Review.

6

Pneumonitis in Irradiated Lungs After Nivolumab: A Brief Communication and Review of the Literature.

Manapov F, Roengvoraphoj O, Dantes M, Marschner S, Li M, Eze C. Manapov F, et al. J Immunother. 2018 Feb/Mar;41(2):96-99. doi: 10.1097/CJI.0000000000000198. J Immunother. 2018. PMID: 29200082

7

Long-lasting shrinkage in tumor mass after discontinuation of nivolumab treatment.

Kimura H, Sone T, Murata A, Koba H, Tambo Y, Hara J, Abo M, Kasahara K. Kimura H, et al. Lung Cancer. 2017 Jun;108:7-8. doi: 10.1016/j.lungcan.2017.02.013. Epub 2017 Feb 23. Lung Cancer. 2017. PMID: 28625651

8

Drug-induced myocarditis after nivolumab treatment in a patient with PDL1- negative squamous cell carcinoma of the lung.

Semper H, Muehlberg F, Schulz-Menger J, Allewelt M, Grohé C. Semper H, et al. Lung Cancer. 2016 Sep;99:117-9. doi: 10.1016/j.lungcan.2016.06.025. Epub 2016 Jul 1. Lung Cancer. 2016. PMID: 27565924

9

Severe nivolumab-induced pneumonitis preceding durable clinical remission in a patient with refractory, metastatic lung squamous cell cancer: a case report.

Li H, Ma W, Yoneda KY, Moore EH, Zhang Y, Pu LL, Frampton GM, Molmen M, Stephens PJ, Li T. Li H, et al. J Hematol Oncol. 2017 Feb 28;10(1):64. doi: 10.1186/s13045-017-0433-z. J Hematol Oncol. 2017. PMID: 28245875 Free PMC article.

10

Radiologic features of pneumonitis associated with nivolumab in non-small-cell lung cancer and malignant melanoma.

Baba T, Sakai F, Kato T, Kusumoto M, Kenmotsu H, Sugiura H, Tominaga J, Oikado K, Sata M, Endo M, Yanagawa N, Sasaki S, Iwasawa T, Saito Y, Fujiwara Y, Ohe Y, Yamazaki N, Sakamoto T, Koshiba T, Kuwano K. Baba T, et al. Future Oncol. 2019 Jun;15(16):1911-1920. doi: 10.2217/fon-2019-0102. Epub 2019 Apr 25. Future Oncol. 2019. PMID: 31020849 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

168 results

Results by year